Qualifying conditions for a Georgia medical cannabis card

End-stage cancer or cancer whose treatment produces wasting, nausea, or severe pain qualifies under Georgia SB 220.

Amyotrophic lateral sclerosis is a qualifying condition under Georgia SB 220 at any stage after diagnosis.

Any seizure disorder — including epilepsy that has not responded to conventional therapy — qualifies under Georgia SB 220.

Severe or end-stage multiple sclerosis is a qualifying condition under Georgia SB 220.

Crohn's disease is a qualifying condition under Georgia SB 220.

Mitochondrial disease is a qualifying condition under Georgia SB 220.

Parkinson's disease is a qualifying condition under Georgia SB 220.

Sickle cell disease is a qualifying condition under Georgia SB 220.

Severe Tourette's syndrome is a qualifying condition under Georgia SB 220.

Autism spectrum disorder is a qualifying condition under Georgia SB 220 — for adults at any level, and for minors with severe autism.

Epidermolysis bullosa is a qualifying condition under Georgia SB 220.

Severe Alzheimer's disease is a qualifying condition under Georgia SB 220.

End-stage AIDS is a qualifying condition under Georgia SB 220.

Severe peripheral neuropathy is a qualifying condition under Georgia SB 220.

Any patient enrolled in a hospice program qualifies under Georgia SB 220, regardless of underlying diagnosis.

Intractable pain — severe, chronic pain that has not responded to conventional therapy — is a qualifying condition under Georgia SB 220.

PTSD from direct trauma is a qualifying condition under Georgia SB 220 for patients age 18 and older.

Chronic or severe hepatitis C is a qualifying condition under Georgia SB 220.

Severe vascular disease is a qualifying condition under Georgia SB 220.